Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease

NCT02896816 is registered in ClinicalTrials.gov with Spaulding Rehabilitation Hospital as lead sponsor.

NCT NCT02896816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02896816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease
Lead sponsor
Spaulding Rehabilitation Hospital
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2016
Completion date
May 25, 2021
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson